Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Biopharmaceutical company reports profitable third quarter
December 16th, 2004
Unigene Laboratories, Inc. (UGNE) announced its financial results for the 3 and 9-month periods ended September 30, 2004. Unigene's net income for the 3 months ended September 30, 2004 was $932,000, compared to a net loss of $3,171,000 for the 3 months ended September 30, 2003. Revenue for the 3 months ended September 30, 2004 was $5,216,000 compared to $118,000 for the 3 months ended September 30, 2003. Unigene's net loss for the 9 months ended September 30, 2004 was $4,195,000 compared to a net loss of $4,254,000 for the 9 months ended September 30, 2003. Revenue for the 9 months ended September 30, 2004 was $6,409,000 compared to $5,657,000 for...
Source: Women's Health Weekly (2004-12-16)
|
